These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1335642)

  • 21. Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters.
    Lee SD; Chan CY; Yu MI; Wang YJ; Lo KJ; Safary A
    Am J Gastroenterol; 1996 Jul; 91(7):1360-2. PubMed ID: 8677995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines.
    Van Herck K; Beutels P; Van Damme P; Beutels M; Van den Dries J; Briantais P; Vidor E
    J Med Virol; 2000 Jan; 60(1):1-7. PubMed ID: 10568755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose response study of an inactivated hepatitis A virus vaccine.
    Carlsson RM; Claesson BA; Iwarson SA
    J Hepatol; 1993; 18 Suppl 2():S41-5. PubMed ID: 8182272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity of two versus three injections of inactivated hepatitis A vaccine in adults.
    Chen XQ; Bülbül M; de Gast GC; van Loon AM; Nalin DR; van Hattum J
    J Hepatol; 1997 Feb; 26(2):260-4. PubMed ID: 9059944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Active immunization against hepatitis A. Comparison of various immunization schedules].
    Müller R; Bock HL; Clemens R; Jilg W
    Dtsch Med Wochenschr; 1993 Aug; 118(31):1101-4. PubMed ID: 8393760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous vaccination against hepatitis A and B: results of a controlled study.
    Ambrosch F; André FE; Delem A; D'Hondt E; Jonas S; Kunz C; Safary A; Wiedermann G
    Vaccine; 1992; 10 Suppl 1():S142-5. PubMed ID: 1335647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous active and passive immunization against hepatitis A studied in a population of travellers.
    Wagner G; Lavanchy D; Darioli R; Pécoud A; Brulein V; Safary A; Frei PC
    Vaccine; 1993; 11(10):1027-32. PubMed ID: 8212822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune response after hepatitis A vaccination in haemodialysis patients: comparison with hepatitis B vaccination.
    Kuramoto I; Fujiyama S; Matsushita K; Sato T
    J Gastroenterol Hepatol; 1994; 9(3):228-31. PubMed ID: 8054520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and laboratory observations following oral or intramuscular administration of a live attenuated hepatitis A vaccine candidate.
    Sjogren MH; Purcell RH; McKee K; Binn L; Macarthy P; Ticehurst J; Feinstone S; Caudill J; See A; Hoke C
    Vaccine; 1992; 10 Suppl 1():S135-7. PubMed ID: 1335645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of two immunization schedules with an inactivated hepatitis A vaccine (AvaximTM).
    Vidor E; Ratheau C; Briantais P; Vuillier D
    J Travel Med; 1998 Dec; 5(4):167-72. PubMed ID: 9876189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children.
    Balcarek KB; Bagley MR; Pass RF; Schiff ER; Krause DS
    J Infect Dis; 1995 Mar; 171 Suppl 1():S70-2. PubMed ID: 7876652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of hepatitis A antibody response to vaccination by an enzyme immunoassay.
    Zuckerman JN; Powell L; Lequin RM; Zuckerman AJ
    J Virol Methods; 1996 Jan; 56(1):27-31. PubMed ID: 8690763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the reactogenicity and immunogenicity of two different dose levels of hepatitis A vaccine in healthy children and adolescents.
    Poovorawan Y; Kosuwon P; Sutra S; Theamboonlers A; Vimolket T; Safary A
    Asian Pac J Allergy Immunol; 1998; 16(2-3):111-7. PubMed ID: 9876949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of an inactivated hepatitis A vaccine administered according to two different schedules and the interference of other "travellers" vaccines with the immune response.
    Bienzle U; Bock HL; Kruppenbacher JP; Hofmann F; Vogel GE; Clemens R
    Vaccine; 1996 Apr; 14(6):501-5. PubMed ID: 8782347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time course of hepatitis A antibody production after active, passive and active/passive immunisation: the results are highly dependent on the antibody test system used.
    Berger R; Just M; Althaus B
    J Virol Methods; 1993 Aug; 43(3):287-97. PubMed ID: 8408443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity and safety of a new inactivated hepatitis A vaccine in a comparative study.
    Goilav C; Zuckerman J; Lafrenz M; Vidor E; Lauwers S; Ratheau C; Benichou G; Zuckerman A
    J Med Virol; 1995 Jul; 46(3):287-92. PubMed ID: 7561805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Protection of adolescents against hepatitis A].
    Puntarić D; Baklaić Z; Ljubicíc M; Vodopija I
    Lijec Vjesn; 1996 Oct; 118(10):241-3. PubMed ID: 9132523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis A vaccine: persistence of antibodies 5 years after the first vaccination.
    Totos G; Gizaris V; Papaevangelou G
    Vaccine; 1997 Aug; 15(11):1252-3. PubMed ID: 9286052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine.
    Dagan R; Greenberg D; Goldenbertg-Gehtman P; Vidor E; Briantais P; Pinsk V; Athias O; Dumas R
    Vaccine; 1999 Apr; 17(15-16):1919-25. PubMed ID: 10217590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A single vaccination with an inactivated hepatitis A liposome vaccine induces protective antibodies after only two weeks.
    Just M; Berger R; Dreschsler H; Brantschen S; Glück R
    Vaccine; 1992; 10(11):737-9. PubMed ID: 1441728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.